Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
Chubb
Johnson and Johnson
UBS
Medtronic
Fish and Richardson
Deloitte
AstraZeneca
Moodys

Generated: August 19, 2017

DrugPatentWatch Database Preview

Q-PAM Drug Profile

« Back to Dashboard

Which patents cover Q-pam, and when can generic versions of Q-pam launch?

Q-pam is a drug marketed by Quantum Pharmics and is included in six NDAs.

The generic ingredient in Q-PAM is diazepam. There are eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the diazepam profile page.

Summary for Tradename: Q-PAM

Patents:0
Applicants:1
NDAs:6
Bulk Api Vendors: see list47
Clinical Trials: see list21
Patent Applications: see list5,857
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:Q-PAM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics
Q-PAM
diazepam
TABLET;ORAL070423-001Dec 12, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
Q-PAM
diazepam
TABLET;ORAL072431-001Apr 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
Q-PAM
diazepam
TABLET;ORAL070424-001Dec 12, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
Q-PAM
diazepam
TABLET;ORAL070425-001Dec 12, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
Q-PAM
diazepam
TABLET;ORAL072433-001Apr 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Johnson and Johnson
Julphar
Argus Health
Fuji
Boehringer Ingelheim
QuintilesIMS
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot